shuttle plasmids

Shuttle plasmids into which antigens are inserted are available from a discontinued clinical program where an HSV vector expressing full length tyrosinase, gp100 and MART-1 was used to transduce DC from melanoma patients which were then to be used for vaccination.

These could be of use to the project if partners would like to use HSV-based technology for the delivery of antigens to DC.

created over 16 years ago (2 March 2009)    last modified over 13 years ago (28 September 2011)   [ RDF ]   [ RelFinder ]